NCT07659756Recruiting
Global Healthcare Study on Atopic Dermatitis
Source: ClinicalTrials.gov · Last updated 22 Jun 2026
Brief summary (registry, in English)
The Global Healthcare Study on Atopic Dermatitis (GHSAD) is an international, multicenter observational study hosted by the University of Zurich (UZH) investigating healthcare access, treatment patterns, disease severity, and quality of life in patients with atopic dermatitis. The study collects standardized clinical data from routine medical records to identify disparities in healthcare delivery and outcomes across different healthcare systems.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 9600 (estimated)
- First submitted
- 15 Jun 2026
- Start date
- Jan 2025
- Primary completion date
- Dec 2029
- Lead sponsor
- Julia Tatjana Maul
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT07659756
What you commit to
- Study type: Observational
- Planned participants: 9600
- From Jan 2025 to the primary completion date, Dec 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Inability to provide informed consent.
- Datasets with ambiguous or unclear diagnosis.
Who the study is looking for
- Signed General Consent Form, or equivalent document
- Confirmed diagnosis of Atopic Dermatitis
Age in the registry: 14 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Zurich Coordinator of this site? Confirm its status | Zurich | Switzerland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.